These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37306999)

  • 1. Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care System.
    Martens KL; Li A; La J; May SB; Swinnerton KN; Tosi H; Elbers DC; Do NV; Brophy MT; Gaziano JM; Lotfollahzadeh S; Chitalia V; Ravid K; Fillmore NR
    JAMA Netw Open; 2023 Jun; 6(6):e2317945. PubMed ID: 37306999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and Risk Factors for Venous Thromboembolism Among Hospitalized Medical Patients.
    Neeman E; Liu V; Mishra P; Thai KK; Xu J; Clancy HA; Schlessinger D; Liu R
    JAMA Netw Open; 2022 Nov; 5(11):e2240373. PubMed ID: 36409498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations.
    da Costa WL; Guffey D; Oluyomi A; Bandyo R; Rosales O; Wallace CD; Granada C; Riaz N; Fitzgerald M; Garcia DA; Carrier M; Amos CI; Flowers CR; Li A
    Am J Hematol; 2022 Aug; 97(8):1044-1054. PubMed ID: 35638475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
    Gulati S; Hsu CY; Shah S; Shah PK; Zon R; Alsamarai S; Awosika J; El-Bakouny Z; Bashir B; Beeghly A; Berg S; de-la-Rosa-Martinez D; Doroshow DB; Egan PC; Fein J; Flora DB; Friese CR; Fromowitz A; Griffiths EA; Hwang C; Jani C; Joshi M; Khan H; Klein EJ; Heater NK; Koshkin VS; Kwon DH; Labaki C; Latif T; McKay RR; Nagaraj G; Nakasone ES; Nonato T; Polimera HV; Puc M; Razavi P; Ruiz-Garcia E; Saliby RM; Shastri A; Singh SRK; Tagalakis V; Vilar-Compte D; Weissmann LB; Wilkins CR; Wise-Draper TM; Wotman MT; Yoon JJ; Mishra S; Grivas P; Shyr Y; Warner JL; Connors JM; Shah DP; Rosovsky RP;
    JAMA Oncol; 2023 Oct; 9(10):1390-1400. PubMed ID: 37589970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
    Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
    JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and Ethnic Disparities in Survival Among People With Second Primary Cancer in the US.
    Sung H; Nisotel L; Sedeta E; Islami F; Jemal A
    JAMA Netw Open; 2023 Aug; 6(8):e2327429. PubMed ID: 37540510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer.
    Khorana AA; Palaia J; Rosenblatt L; Pisupati R; Huang N; Nguyen C; Barron J; Gallagher K; Bond TC
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
    Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
    J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
    Alam AU; Karkhaneh M; Sun HL; Wu C
    Thromb Res; 2021 Mar; 199():59-66. PubMed ID: 33429125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
    Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy.
    Li A; May SB; La J; Martens KL; Amos CI; Flowers CR; Do NV; Brophy MT; Chitalia V; Ravid K; Gaziano JM; Fillmore NR
    Am J Hematol; 2023 Aug; 98(8):1214-1222. PubMed ID: 37161855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for cancer-associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE-PACC) study.
    Douce DR; Holmes CE; Cushman M; MacLean CD; Ades S; Zakai NA
    J Thromb Haemost; 2019 Dec; 17(12):2152-2159. PubMed ID: 31423717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study.
    Wu JT; La J; Branch-Elliman W; Huhmann LB; Han SS; Parmigiani G; Tuck DP; Brophy MT; Do NV; Lin AY; Munshi NC; Fillmore NR
    JAMA Oncol; 2022 Feb; 8(2):281-286. PubMed ID: 34854921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Survival Outcomes of Gastrointestinal Stromal Tumors.
    Alvarez CS; Piazuelo MB; Fleitas-Kanonnikoff T; Ruhl J; Pérez-Fidalgo JA; Camargo MC
    JAMA Netw Open; 2024 Aug; 7(8):e2428828. PubMed ID: 39158910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between epidermal growth factor receptor-tyrosine kinase inhibitors and venous thromboembolism among older patients with advanced non-small cell lung cancer.
    Byun JY; Aiyeolemi A; Qdaisat A; Park C
    Cancer; 2024 Oct; 130(20):3412-3425. PubMed ID: 38848305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementia Risk and Disadvantaged Neighborhoods.
    Dintica CS; Bahorik A; Xia F; Kind A; Yaffe K
    JAMA Neurol; 2023 Sep; 80(9):903-909. PubMed ID: 37464954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.